EIF2AK2 and neoplasm: We have finally checked the activation pattern of PKR in plitidepsin-resistant tumour cells with reduced eEF1A2 protein levels.9 Treatment with 450 nM plitidepsin induced a clear, time-dependent increase in phosphorylated PKR in HeLa cells (Fig. 3d).